ADAMTS1

ADAM metallopeptidase with thrombospondin type 1 motif 1, the group of ADAM metallopeptidases with thrombospondin type 1 motif

Basic information

Region (hg38): 21:26835755-26845409

Links

ENSG00000154734NCBI:9510OMIM:605174HGNC:217Uniprot:Q9UHI8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant prognathism (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADAMTS1 gene.

  • not_specified (111 variants)
  • not_provided (23 variants)
  • Premature_ovarian_failure (1 variants)
  • Nonsyndromic_hearing_impairment (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006988.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
6
clinvar
10
missense
1
clinvar
108
clinvar
9
clinvar
3
clinvar
121
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 1 108 13 9

Highest pathogenic variant AF is 0.0000130104

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADAMTS1protein_codingprotein_codingENST00000284984 99663
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7160.2841257200281257480.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6675045480.9200.00002836267
Missense in Polyphen212257.710.822643002
Synonymous-0.05172322311.000.00001331895
Loss of Function4.63839.30.2040.00000201453

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008670.0000867
Ashkenazi Jewish0.000.00
East Asian0.0001640.000163
Finnish0.00009250.0000924
European (Non-Finnish)0.0001170.000105
Middle Eastern0.0001640.000163
South Asian0.0002670.000229
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cleaves aggrecan, a cartilage proteoglycan, at the '1938-Glu-|-Leu-1939' site (within the chondroitin sulfate attachment domain), and may be involved in its turnover (By similarity). Has angiogenic inhibitor activity. Active metalloprotease, which may be associated with various inflammatory processes as well as development of cancer cachexia. May play a critical role in follicular rupture. {ECO:0000250, ECO:0000269|PubMed:10438512}.;
Pathway
VEGFA-VEGFR2 Signaling Pathway;Endochondral Ossification;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Degradation of the extracellular matrix;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation (Consensus)

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
0.398
rvis_EVS
0.07
rvis_percentile_EVS
59.17

Haploinsufficiency Scores

pHI
0.475
hipred
Y
hipred_score
0.793
ghis
0.487

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.829

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Adamts1
Phenotype
endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype;

Gene ontology

Biological process
ovulation from ovarian follicle;kidney development;proteolysis;integrin-mediated signaling pathway;negative regulation of cell population proliferation;heart trabecula formation;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration
Cellular component
basement membrane;cytoplasmic vesicle;collagen-containing extracellular matrix
Molecular function
metalloendopeptidase activity;heparin binding;metallopeptidase activity;zinc ion binding